Spondylolisthesis

• CLINICAL_TRIALS withdrawal · 2022-08-19
  Clinical Trial Update: Peri-Incisional Drug Injection in Lumbar Spine Surgery [Phase 3]

  A Phase 3 trial investigating peri-incisional drug injection in lumbar spine surgery has been withdrawn.

• EMA withdrawal · 2016-07-14
  EMA Withdrawn: Opgenra (eptotermin alfa) — Olympus Biotech International Limited

  EMA withdrew Opgenra (eptotermin alfa) from the market; previously indicated for spondylolisthesis.